Results 101 to 110 of about 84,576 (334)

Atrial cardiomyopathy: From healthy atria to atrial failure. A clinical consensus statement of the Heart Failure Association of the ESC

European Journal of Heart Failure, EarlyView.
The diagnosis of atrial cardiomyopathy (AtCM) requires electrical atrial dysfunction, with evidence of either mechanical atrial dysfunction, atrial enlargement, or excessive atrial fibrosis. The diagnostic cut‐points presented are for standard electrocardiogram and echocardiogram studies (see Figure 1 for further detail).
Jerremy Weerts, Otilia Țica, Julia Aranyo, Christian Basile, Angelina Borizanova‐Petkova, Josip Andjelo Borovac, Massimiliano Camilli, Martin Eichenlaub, Emiliano Fiori, Tim Van Loon, Coenraad Withaar, Diana Zakarkaitė, Matthias D. Zink, Marianna Adamo, Alberto Aimo, Elena Arbelo, Felipe Bisbal Van Bylen, Dimitrios T. Farmakis, Dobromir Dobrev, Jelena Čelutkienė, Michael Böhm, Andrew Coats, Marco Metra, Giuseppe Rosano, Frank Ruschitzka, Antoni Bayes‐Genis, Dipak Kotecha   +26 more
wiley   +1 more source

Bilateral pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension: the youngest case in our region

Türk Kardiyoloji Derneği Arşivi, 2013
The insertion of ventriculoatrial (VA) shunts for the treatment of hydrocephalus is associated with the development of chronic thromboembolic pulmonary hypertension (CTEPH).
Rana Olguntürk, Ayhan Çevik, Serdar Kula, Bedrettin Yıldızeli   +3 more
doaj   +1 more source

Life expectancy after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: a Swedish single-center study

Pulmonary Circulation, 2020
Pulmonary endarterectomy is the guideline recommended treatment for chronic thromboembolic pulmonary hypertension, in addition to life-long anticoagulation therapy.
Janica Kallonen, Natalie Glaser, Fredrik Bredin, Matthias Corbascio, Ulrik Sartipy   +4 more
doaj   +1 more source

Numerical simulation of blood flow and pressure drop in the pulmonary arterial and venous circulation [PDF]

, 2014
A novel multiscale mathematical and computational model of the pulmonary circulation is presented and used to analyse both arterial and venous pressure and flow. This work is a major advance over previous studies by Olufsen et al. (Ann Biomed Eng 28:1281–
AC Burton, AJ Peacock, AJ Peacock, AR Pries, BI Levy, BN Steele, CA Figueroa, CA Taylor, Charles S. Peskin, Christopher Sainsbury, CW Li, D Mukerjee, DJ Patel, DJ Patel, E Hachulla, E Peskin, EH Hollander, EO Attinger, ER Weibel, FN Vosse van de, FY Zhuang, FY Zhuang, G Simonneau, Gareth D. A. Vaughan, GH Fonseca, GS Krenz, HBM Uylings, IE Vignon-Clementel, J Alastruey, J Fullana, JC Greenfield, JE Hall, JT Reeves, JW Lankhaar, K Azer, KS Matthys, L Formaggia, M. Umar Qureshi, Martin Johnson, Mette S. Olufsen, MS Olufsen, MS Olufsen, MS Olufsen, MS Pollanen, N Suwa, N Xiao, N. A. Hill, O Sitbon, P Dartevelle, P Herve, P Reymond, PH Bovendeerd, PJ Barnes, R Kato, RB Clipp, RB Clipp, RF Machado, RJ Barst, RL Evans, RM Tuder, RT Yen, S Singhal, SJ Sherwin, V Castelain, W Cousins, W Huang, WM Thurlbeck, WR Milnor, WW Nichols, Y Gao, Y Huo, Y Kawahira, YC Fung, YH Kim   +73 more
core   +1 more source

Update on Chronic Thromboembolic Pulmonary Hypertension [PDF]

Circulation, 2014
Chronic thromboembolic pulmonary hypertension (CTEPH) is a distinct pulmonary vascular disease caused by chronic obstruction of major pulmonary arteries that is amenable to cure by pulmonary endarterectomy (PEA). Main features of CTEPH as opposed to pulmonary arterial hypertension (PAH) are a nonhomogeneous distribution of disease in segments of the ...
Irene Marthe, Lang, Michael, Madani
openaire   +2 more sources

Exercise haemodynamics in pulmonary hypertension – a prospective pressure–volume loop study on right ventricular adaptation and prognosis

European Journal of Heart Failure, EarlyView.
Multimodal assessment during exercise distinguishes clinically relevant right ventricular (RV) adaptation patterns (homeometric and heterometric adaptation) in pulmonary hypertension. Disease controls are patients with invasive exclusion of pulmonary hypertension.
Bruno R. Thal, Zvonimir A. Rako, Nils C. Kremer, Athiththan Yogeswaran, Patrick Janetzko, Selin Yildiz, Stephan Rosenkranz, Hossein Ardeschir Ghofrani, Werner Seeger, Friedrich Grimminger, Khodr Tello   +10 more
wiley   +1 more source

Rate-Control or Rhythm-Contol: Where do we stand? [PDF]

, 2005
Atrial fibrillation is the most common sustained rhythm disturbance and its prevalence is increasing worldwide due to the progressive aging of the population.
A, Dello Russo, F, Andreotti, F, Bellocci, G, Pelargonio, G, Trotta, L, Testa, M, Casella   +6 more
core   +1 more source

Heart failure with preserved ejection fraction in cancer patients and survivors. A scientific statement of the Heart Failure Association of the ESC and the ESC Council of Cardio‐Oncology

European Journal of Heart Failure, EarlyView.
Specific characteristics of HFpEF universal definition in cancer patients. Abstract Heart failure with preserved ejection fraction (HFpEF) is increasingly recognized in cancer patients and survivors, yet it remains underdiagnosed and its epidemiology largely unknown.
Kalliopi Keramida, Teresa Lopez‐Fernandez, Markus S. Anker, Mark C. Petrie, Pietro Ameri, Lisa J. Anderson, Jutta Bergler‐Klein, Anita Deswal, Dimitrios Farmakis, Borja Ibañez, Carolyn S.P. Lam, Ninian N. Lang, Alexander R. Lyon, Mariana Mirabel, Brenda Moura, Walter J. Paulus, Amina Rakisheva, Gianluigi Savarese, Michele Senni, Carlo Gabriele Tocchetti, Marco Metra, Gerasimos Filippatos   +21 more
wiley   +1 more source

Interatrial shunt devices for heart failure with normal ejection fraction: a technology update [PDF]

, 2017
Heart failure with normal ejection fraction (HeFNEF) accounts for ~50% of heart failure admissions. Its pathophysiology and diagnostic criteria are yet to be defined clearly which may hinder the search for effective treatments.
Clark, Andrew L., Cuthbert, Joseph J., Pellicori, Pierpaolo   +2 more
core   +3 more sources

Familial Chronic Thromboembolic Pulmonary Hypertension [PDF]

Chest, 2016
Chronic thromboembolic pulmonary hypertension (CTEPH) is an uncommon disease that is the most serious complication associated with unresolved pulmonary embolism. This disease has several risk factors, but no familial pattern has been described. Few thrombophilic conditions have been reported to increase risk of CTEPH, and none of the hereditary ...
Julianna, Desmarais, C Gregory, Elliott
openaire   +2 more sources